ES2084679T3 - Aplicacion de n-metil(piridil-3)-2 tetrahidrotiopiranocarbotioamida-2-oxido-1 a la preparacion de medicamentos destinados al tratamiento de la insuficiencia coronaria. - Google Patents

Aplicacion de n-metil(piridil-3)-2 tetrahidrotiopiranocarbotioamida-2-oxido-1 a la preparacion de medicamentos destinados al tratamiento de la insuficiencia coronaria.

Info

Publication number
ES2084679T3
ES2084679T3 ES90403060T ES90403060T ES2084679T3 ES 2084679 T3 ES2084679 T3 ES 2084679T3 ES 90403060 T ES90403060 T ES 90403060T ES 90403060 T ES90403060 T ES 90403060T ES 2084679 T3 ES2084679 T3 ES 2084679T3
Authority
ES
Spain
Prior art keywords
methyl
preparation
treatment
tetrahidrotiopiranocarbotioamida
piridil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90403060T
Other languages
English (en)
Inventor
Icilio Cavero
Serge Mondot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Application granted granted Critical
Publication of ES2084679T3 publication Critical patent/ES2084679T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

APLICACION DEL N-METIL(PIRIDIL-3) -2 TETRAHIDROTIOPIRANOCARBOTIOAMIDA -2 OXIDO OMEROS 1S, 2S Y 1R, 2R O EN FORMA DEL ISOMERO 1R, 2R A LA PREPARACION DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO DE LAS INSUFICIENCIAS CORONARIAS.
ES90403060T 1989-10-31 1990-10-30 Aplicacion de n-metil(piridil-3)-2 tetrahidrotiopiranocarbotioamida-2-oxido-1 a la preparacion de medicamentos destinados al tratamiento de la insuficiencia coronaria. Expired - Lifetime ES2084679T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8914272A FR2653662B1 (fr) 1989-10-31 1989-10-31 Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne.

Publications (1)

Publication Number Publication Date
ES2084679T3 true ES2084679T3 (es) 1996-05-16

Family

ID=9386962

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90403060T Expired - Lifetime ES2084679T3 (es) 1989-10-31 1990-10-30 Aplicacion de n-metil(piridil-3)-2 tetrahidrotiopiranocarbotioamida-2-oxido-1 a la preparacion de medicamentos destinados al tratamiento de la insuficiencia coronaria.

Country Status (17)

Country Link
US (1) US5426117A (es)
EP (1) EP0429324B1 (es)
JP (1) JPH03153683A (es)
KR (1) KR910007524A (es)
AT (1) ATE135910T1 (es)
AU (1) AU637419B2 (es)
CA (1) CA2028986A1 (es)
DE (1) DE69026204T2 (es)
DK (1) DK0429324T3 (es)
ES (1) ES2084679T3 (es)
FR (1) FR2653662B1 (es)
GR (1) GR3019441T3 (es)
HU (1) HU212502B (es)
IE (1) IE72476B1 (es)
IL (1) IL96161A (es)
PT (1) PT95757B (es)
ZA (1) ZA908678B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373173B1 (ko) * 1996-11-18 2003-08-19 주식회사 코오롱 차광성 및 성형성이 우수한 폴리에틸렌테레프탈레이트 수지 조성물
KR102068928B1 (ko) * 2019-05-17 2020-01-21 민은홍 광고수단으로 전환사용이 가능한 레일 조명

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528849B1 (fr) * 1982-06-17 1985-06-21 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
FR2653662A1 (fr) 1991-05-03
ATE135910T1 (de) 1996-04-15
HU212502B (en) 1996-07-29
IE903901A1 (en) 1991-05-08
IL96161A (en) 1996-12-05
GR3019441T3 (en) 1996-06-30
CA2028986A1 (fr) 1991-05-01
EP0429324A3 (en) 1992-05-27
AU6554790A (en) 1991-05-09
DE69026204T2 (de) 1996-09-05
DE69026204D1 (de) 1996-05-02
FR2653662B1 (fr) 1994-05-13
EP0429324A2 (fr) 1991-05-29
ZA908678B (en) 1991-08-28
HUT59312A (en) 1992-05-28
KR910007524A (ko) 1991-05-30
PT95757A (pt) 1991-09-13
IL96161A0 (en) 1991-07-18
DK0429324T3 (da) 1996-04-29
US5426117A (en) 1995-06-20
EP0429324B1 (fr) 1996-03-27
HU906946D0 (en) 1991-05-28
AU637419B2 (en) 1993-05-27
JPH03153683A (ja) 1991-07-01
IE72476B1 (en) 1997-04-23
PT95757B (pt) 1997-09-30

Similar Documents

Publication Publication Date Title
SE8504720D0 (sv) New drug preparation
NO2002009I2 (no) Tiotropium
NO175287C (no) Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
NO874955L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
NO171851C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromen
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
AU637419B2 (en) Application of a carbothioamine 1-oxide to the preparation of medicinal products for the treatment of coronary insufficiency
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
IT7926564A0 (it) Nuovi derivati 1,6-naftiridinici, procedimento per la loro produzione, nonche' farmaci antidinici e che migliorano la circolazione cerebrale contenenti tali derivati.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
FI924881A7 (fi) Menetelmä (2R, 3E)-4-halo-3-buten-2-olien valmistamiseksi
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
DK101781A (da) Fremgangsmaade til fremstilling af 10/substituerede 5-cyamethylen-dibenzo (a,d) cycloheptener

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 429324

Country of ref document: ES